5-methoxy-N,N-dibutyltryptamine
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
tryptamine derivative |
| gptkbp:CASNumber |
not assigned
|
| gptkbp:category |
psychedelic
substituted tryptamine |
| gptkbp:chemicalFormula |
C17H28N2O
|
| gptkbp:discoveredBy |
gptkb:Alexander_Shulgin
|
| https://www.w3.org/2000/01/rdf-schema#label |
5-methoxy-N,N-dibutyltryptamine
|
| gptkbp:IUPACName |
N,N-dibutyl-2-(5-methoxy-1H-indol-3-yl)ethanamine
|
| gptkbp:legalStatus |
uncontrolled (in most countries)
|
| gptkbp:mentions |
gptkb:TiHKAL
|
| gptkbp:molecularWeight |
276.42 g/mol
|
| gptkbp:otherName |
5-MeO-DBT
|
| gptkbp:psychoactive |
yes
|
| gptkbp:relatedTo |
gptkb:5-MeO-DMT
gptkb:N,N-dibutyltryptamine |
| gptkbp:routeOfAdministration |
oral
smoked |
| gptkbp:structure |
tryptamine core with 5-methoxy and N,N-dibutyl substitutions
|
| gptkbp:bfsParent |
gptkb:5TBO
|
| gptkbp:bfsLayer |
8
|